The present invention relates to novel cephalosporin derivatives, processes for preparing thereof, compositions for preventing and/or treating infectious diseases which comprise the novel cephalosporin derivatives as active components, and the intermediate compounds in the synthesis of cephalosporin derivatives and processes for producing thereof.
The present invention is based on the selection of groups containing a condensed heterocyclic ring, particularly a triazolopyrimidine ring or a thiadiazolopyrimidine ring, as substituents at the 3- position of the cephem skeleton, and of groups containing a catechol moiety, particularly a catechol carboxymethyloxyimino moiety or a catechol carboxyimino moiety, as substituents at the 7-position of the cephem skeleton.
The compounds of the present invention containing the aforementioned substituents have a strong antibacterial activity against Gram-negative bacteria and also against Gram-positive bacteria including methicillin-resistant Staphylococcus aureus. These compounds are extremely useful for the treatment of infectious diseases.
本发明涉及新型
头孢菌素衍
生物、其制备工艺、包含新型
头孢菌素衍
生物作为活性成分的预防和/或治疗传染性疾病的组合物,以及合成
头孢菌素衍
生物的中间化合物及其生产工艺。
本发明的基础是选择含有缩合杂环的基团,特别是三唑并
嘧啶环或
噻二唑并
嘧啶环,作为
头孢菌素骨架 3-位上的取代基,并选择含有
邻苯二酚分子的基团,特别是
邻苯二酚羧甲基亚
氨基分子或
邻苯二酚羧基亚
氨基分子,作为
头孢菌素骨架 7-位上的取代基。
含有上述取代基的本发明化合物对革兰氏阴性菌和革兰氏阳性菌(包括耐
甲氧西林金黄色葡萄球菌)具有很强的抗菌活性。这些化合物对治疗传染性疾病极为有用。